• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种用于多中心生存研究中潜在异质性治疗效果的部分异质性加权融合学习方法。

A partially heterogeneous weighted fusion learning method for potential heterogeneous treatment effect in multi-site survival study.

作者信息

Huang Chen, Wei Kecheng, Yu Yongfu, Qin Guoyou

机构信息

Department of Biostatistics, Key Laboratory for Health Technology Assessment, Key Laboratory of Public Health Safety of Ministry of Education, School of Public Health, National Commission of Health, Fudan University, Shanghai, China.

Shanghai Stomatological Hospital & School of Stomatology, Fudan University, Shanghai, China.

出版信息

BMC Med Res Methodol. 2025 Jul 1;25(1):169. doi: 10.1186/s12874-025-02612-3.

DOI:10.1186/s12874-025-02612-3
PMID:40597724
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12211222/
Abstract

BACKGROUND

In multi-site studies in clinical practice, the treatment effects may exhibit potential heterogeneity across different sites. Additionally, propensity score methods used to adjust for confounding may suffer from model misspecification, which can lead to biased estimates. Addressing both the potential heterogeneity of site-specific treatment effects and the issues of model misspecification in the context of multi-site survival data is a critical area that warrants further research.

METHODS

We propose a novel partially heterogeneous weighted fusion learning method. This approach is designed to simultaneously identify and estimate potential heterogeneous treatment effects across sites, while also improving robustness against model misspecification in the estimation of survival causal effects across different sites. We evaluate the performance of this method through simulation studies and apply it to the real-world data from the Surveillance, Epidemiology, and End Result (SEER) database to assess whether the survival effect of surgery with adjuvant radiation therapy for breast cancer patients differs across sites in a multi-site study.

RESULTS

Simulation studies demonstrate that our proposed method accurately identifies the potential heterogeneous treatment effects, and when the candidate models include the correct model, our method performs comparably to methods based on correctly specified propensity score models in estimating the site-specific hazard ratios. The application of our method to the SEER database revealed two distinct survival effects of surgery with adjuvant radiation therapy for breast cancer patients across sites. However, compared to our method, traditional methods that pool all sites together failed to identify this heterogeneity, while analyzing each site individually led to a reduction in statistical power.

CONCLUSION

This study introduces a partially heterogeneous weighted fusion learning method for survival data that effectively identifies potential inter-site heterogeneity in treatment effects, while simultaneously addressing the issue of model misspecification.

摘要

背景

在临床实践的多中心研究中,不同中心的治疗效果可能存在潜在的异质性。此外,用于调整混杂因素的倾向评分方法可能存在模型误设问题,这可能导致估计有偏差。在多中心生存数据的背景下,解决特定中心治疗效果的潜在异质性以及模型误设问题是一个关键领域,值得进一步研究。

方法

我们提出了一种新颖的部分异质性加权融合学习方法。该方法旨在同时识别和估计不同中心潜在的异质性治疗效果,同时在估计不同中心的生存因果效应时提高对模型误设的稳健性。我们通过模拟研究评估该方法的性能,并将其应用于监测、流行病学和最终结果(SEER)数据库的真实世界数据,以评估在多中心研究中乳腺癌患者辅助放疗手术的生存效果在不同中心是否存在差异。

结果

模拟研究表明,我们提出的方法能够准确识别潜在的异质性治疗效果,并且当候选模型包括正确模型时,我们的方法在估计特定中心的风险比方面与基于正确设定的倾向评分模型的方法表现相当。我们的方法应用于SEER数据库揭示了乳腺癌患者辅助放疗手术在不同中心有两种不同的生存效果。然而,与我们的方法相比,将所有中心合并在一起的传统方法未能识别这种异质性,而单独分析每个中心会导致统计功效降低。

结论

本研究介绍了一种用于生存数据的部分异质性加权融合学习方法,该方法能有效识别治疗效果中潜在的中心间异质性,同时解决模型误设问题。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03b0/12211222/a09418cfd592/12874_2025_2612_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03b0/12211222/e527fcdde926/12874_2025_2612_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03b0/12211222/a09418cfd592/12874_2025_2612_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03b0/12211222/e527fcdde926/12874_2025_2612_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03b0/12211222/a09418cfd592/12874_2025_2612_Fig2_HTML.jpg

相似文献

1
A partially heterogeneous weighted fusion learning method for potential heterogeneous treatment effect in multi-site survival study.一种用于多中心生存研究中潜在异质性治疗效果的部分异质性加权融合学习方法。
BMC Med Res Methodol. 2025 Jul 1;25(1):169. doi: 10.1186/s12874-025-02612-3.
2
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.原发性手术后晚期上皮性卵巢癌患者残留病灶对生存预后的影响。
Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD015048. doi: 10.1002/14651858.CD015048.pub2.
3
Are Current Survival Prediction Tools Useful When Treating Subsequent Skeletal-related Events From Bone Metastases?当前的生存预测工具在治疗骨转移后的骨骼相关事件时有用吗?
Clin Orthop Relat Res. 2024 Sep 1;482(9):1710-1721. doi: 10.1097/CORR.0000000000003030. Epub 2024 Mar 22.
4
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
5
Exercise for women receiving adjuvant therapy for breast cancer.针对接受乳腺癌辅助治疗的女性的运动
Cochrane Database Syst Rev. 2016 Sep 21;9(9):CD005001. doi: 10.1002/14651858.CD005001.pub3.
6
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.拓扑替康治疗卵巢癌的临床有效性和成本效益的快速系统评价。
Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280.
7
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.
8
A systematic review and economic evaluation of epoetin alpha, epoetin beta and darbepoetin alpha in anaemia associated with cancer, especially that attributable to cancer treatment.促红细胞生成素α、促红细胞生成素β和达比加群酯治疗癌症相关性贫血(尤其是癌症治疗所致贫血)的系统评价与经济学评估
Health Technol Assess. 2007 Apr;11(13):1-202, iii-iv. doi: 10.3310/hta11130.
9
Magnetic resonance perfusion for differentiating low-grade from high-grade gliomas at first presentation.首次就诊时磁共振灌注成像用于鉴别低级别与高级别胶质瘤
Cochrane Database Syst Rev. 2018 Jan 22;1(1):CD011551. doi: 10.1002/14651858.CD011551.pub2.
10
Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer: a systematic review and economic evaluation.拓扑替康、聚乙二醇化脂质体盐酸多柔比星和紫杉醇用于晚期卵巢癌二线或后续治疗:一项系统评价和经济学评估
Health Technol Assess. 2006 Mar;10(9):1-132. iii-iv. doi: 10.3310/hta10090.

本文引用的文献

1
Modern approaches for evaluating treatment effect heterogeneity from clinical trials and observational data.现代方法评估临床试验和观察数据中治疗效果的异质性。
Stat Med. 2024 Sep 30;43(22):4388-4436. doi: 10.1002/sim.10167. Epub 2024 Jul 25.
2
Individual Data Protected Integrative Regression Analysis of High-Dimensional Heterogeneous Data.高维异构数据的个体数据保护整合回归分析
J Am Stat Assoc. 2022;117(540):2105-2119. doi: 10.1080/01621459.2021.1904958. Epub 2021 May 19.
3
Covariate balance-related propensity score weighting in estimating overall hazard ratio with distributed survival data.
带有分布式生存数据的协变量平衡相关倾向评分加权法估计总体风险比。
BMC Med Res Methodol. 2023 Oct 13;23(1):233. doi: 10.1186/s12874-023-02055-8.
4
Capturing heterogeneity in repeated measures data by fusion penalty.融合惩罚捕获重复测量数据中的异质性。
Stat Med. 2021 Apr 15;40(8):1901-1916. doi: 10.1002/sim.8878. Epub 2021 Jan 31.
5
Estimating the marginal hazard ratio by simultaneously using a set of propensity score models: A multiply robust approach.同时使用一组倾向评分模型估计边缘危险比:一种多重稳健方法。
Stat Med. 2021 Feb 28;40(5):1224-1242. doi: 10.1002/sim.8837. Epub 2021 Jan 6.
6
A General Framework for Quantile Estimation with Incomplete Data.用于不完整数据分位数估计的通用框架。
J R Stat Soc Series B Stat Methodol. 2019 Apr;81(2):305-333. doi: 10.1111/rssb.12309. Epub 2019 Jan 6.
7
Exploration of Heterogeneous Treatment Effects via Concave Fusion.通过凹融合探索异质性治疗效果
Int J Biostat. 2019 Sep 20;16(1):ijb-2018-0026. doi: 10.1515/ijb-2018-0026.
8
Fusion Learning Algorithm to Combine Partially Heterogeneous Cox Models.融合学习算法以合并部分异质性Cox模型
Comput Stat. 2019 Mar;34(1):395-414. doi: 10.1007/s00180-018-0827-6. Epub 2018 Jul 17.
9
Treatment Effects in Multicenter Randomized Clinical Trials.多中心随机临床试验中的治疗效果
JAMA. 2019 Mar 26;321(12):1211-1212. doi: 10.1001/jama.2019.1480.
10
Breast Cancer Treatment: A Review.乳腺癌治疗:综述。
JAMA. 2019 Jan 22;321(3):288-300. doi: 10.1001/jama.2018.19323.